Why diagnosing helminth infections can be difficult in frontline healthcare
Who is this article for? Healthcare workers (doctors, nurses, pharmacists, etc.)

Why diagnosing helminth infections can be difficult in frontline healthcare

DIDIDI team

A practical guide for doctors, nurses, pharmacists and other frontline professionals: recognising risk, choosing the right investigation and responding safely when the answer remains uncertain.

A patient has persistent abdominal discomfort, another has anaemia, and a child’s caregiver reports recurrent itching at night. Each presentation may raise the possibility of a worm infection, but none is enough to establish which parasite is responsible—or whether a helminth is responsible at all.

WHO describes many soil-transmitted helminth infections as asymptomatic when light, with heavier infections associated with abdominal symptoms, nutritional effects and weakness. Hookworms can contribute to iron-deficiency anaemia. These familiar presentations make helminthiasis relevant to primary care, but also easy to confuse with other conditions. 1

Testing introduces further uncertainty. In a 2014 meta-analysis, double-slide Kato–Katz sensitivity ranged from 74–95% across the soil-transmitted helminth groups studied in high-intensity infections, falling to 53–80% in low-intensity settings. These are pooled research estimates, not fixed performance values for a particular clinic. They show why “no eggs seen” sometimes answers a narrower question than the clinician intended. 2

This guide focuses on common intestinal helminths, strongyloidiasis and schistosomiasis, with selected situations requiring referral. It supports clinical reasoning alongside national protocols and the laboratory’s validated procedures. The practical sequence is: assess urgency, establish exposure, select a parasite-specific investigation, check specimen quality and make a plan for the result.

1. First identify patients who cannot wait for routine testing

Begin with severity, before arranging stool collection. MSF describes intestinal obstruction from heavy ascariasis, particularly in young children, with abdominal pain, vomiting and constipation. Marked abdominal distension with these features requires urgent assessment, rather than another routine deworming course while awaiting microscopy. 3

Anaemia also needs assessment in its own right. Pallor accompanied by respiratory distress, altered consciousness, shock or other signs of decompensation warrants emergency care under the local anaemia protocol. A possible hookworm contribution must not delay stabilisation or investigation of other causes. 4

Neurological symptoms require a different pathway. New seizures or focal neurological findings should prompt urgent medical assessment; suspected neurocysticercosis requires imaging and sometimes serological testing, rather than a stool test alone. CDC also advises caution with albendazole and praziquantel when cysticercosis is suspected because treatment-associated seizures have been reported. 5 6

Finally, be alert to deterioration during immunosuppression. Strongyloides hyperinfection or disseminated infection can involve severe gastrointestinal and respiratory disease, and eosinophilia may be absent. An exposed patient becoming seriously unwell while receiving corticosteroids needs urgent clinician-led evaluation, with possible strongyloidiasis communicated explicitly. 7

For nurses and pharmacists, these findings are referral triggers. Recognising a possible helminth infection is useful; recognising that the patient needs a higher level of care is the immediate priority.

2. Take an exposure history that changes the investigation

Ask where the person has lived as well as where they have recently travelled. For Strongyloides, remote exposure matters because untreated infection can persist for decades through autoinfection. CDC identifies barefoot contact with contaminated soil and activities such as farming as relevant exposures. 8

For suspected schistosomiasis, ask about swimming, bathing, fishing, washing or wading in freshwater in an endemic area. Record the location and timing. Species distribution affects specimen choice: intestinal schistosomes are usually investigated through stool, whereas S. haematobium eggs are sought in urine. Where both forms occur, freshwater exposure may justify examination of both specimens. 28

When segments or worms have been noticed, ask what the patient actually saw and whether a specimen can be submitted safely through the laboratory. Taenia investigations include examination for eggs and proglottids; asking about passed segments is relevant. Do not assume every visible structure establishes the species. 10

Also document earlier treatment: the medicine, when it was taken and the course completed. A history of unspecified “deworming” does not establish that every relevant helminth was treated. WHO’s strongyloidiasis guidance explains that the diagnostic approach and public-health treatment strategy differ from those for the usual soil-transmitted helminths. 11

Turn these details into a focused request. “Freshwater exposure in a schistosomiasis-endemic district, haematuria” gives the laboratory more useful direction than “parasites?” A brief exposure history can be collected by any trained team member and reviewed by the responsible clinician.

3. Use eosinophils as a clue, not a diagnosis or exclusion test

A complete blood count can help identify anaemia and eosinophilia, but neither finding establishes helminthiasis. CDC’s Yellow Book defines peripheral eosinophilia as an absolute count of at least 500 cells/µL and advises against interpreting the percentage alone. Allergy, drug reactions and several other conditions can also increase eosinophils. 12

The timing of the immune response matters. Eosinophilia may occur while larvae are migrating, before adult worms produce eggs detectable in stool. A negative stool examination early after exposure can therefore coexist with an infection-related eosinophilia. Conversely, frequent exposure or other illness can modify the response. The Yellow Book discussion is primarily written for returned travellers; its expected patterns should not be transferred uncritically to repeatedly exposed endemic populations. 12

In particular, lack of eosinophilia does not exclude Strongyloides infection. CDC makes this explicit in its refugee-health guidance. Use the count alongside exposure, symptoms, medication history and appropriate testing, rather than as permission to stop an investigation. 8

The practical question is: does this result increase concern, and what targeted test or referral would resolve it? It is not: can eosinophilia replace a parasite-specific investigation?

4. Match the specimen and method to the suspected infection

There is no universal “worm test.” The following table is a starting point for discussion with the laboratory, not an instruction to order every investigation.

Clinical clue or exposure Investigation to discuss Important limitation
Suspected Ascaris, Trichuris or hookworm infection Stool parasitology using a locally validated method Light infections may be missed; performance differs between techniques. 1 2
Possible strongyloidiasis, particularly before immunosuppression Strongyloides-specific serology and/or appropriate specialised stool testing Routine stool microscopy alone cannot reliably exclude infection. 7 8
Freshwater exposure with urinary symptoms in an endemic area Urine examination for S. haematobium eggs; filtration where available Dipstick blood supports suspicion but is not definitive individual diagnosis. 9 13
Possible intestinal schistosomiasis Stool examination for eggs; locally validated additional testing where available Urine testing alone does not assess every schistosome species. 13
Persistent nocturnal perianal itching Early-morning perianal tape test An ordinary stool specimen is not the preferred investigation for pinworm. 14
Passage of tapeworm segments Stool and submitted segment examination Taenia eggs do not distinguish the species; further identification may be needed. 10

Ask what the laboratory’s “stool examination” includes. A direct wet mount, a concentration technique and Kato–Katz are different procedures. Do not assume a method designed to detect and count particular eggs also excludes Strongyloides, tissue helminths or every other cause of persistent symptoms. The performance differences documented in the meta-analysis support specifying the diagnostic question. 2 7

For pinworm, explain the collection procedure clearly: CDC recommends sampling first thing in the morning, before washing, toileting or dressing, on three consecutive mornings. Provide the laboratory’s approved tape or collection kit and transport instructions. This is a simple example of improving diagnosis by changing the specimen rather than buying a more advanced instrument. 15

5. Make collection and transport part of the consultation

For stool examination, supply a clean, dry, leakproof container and explain how to avoid contamination with urine, toilet water or soil. Arrange prompt delivery. CDC advises immediate examination, processing or appropriate preservation of fresh specimens; the suitable approach depends on the intended test. 16

When repeat microscopy is indicated, arrange separate specimens rather than several portions from one bowel movement. CDC’s general stool guidance suggests three specimens collected at intervals of two to three days where possible. Follow the receiving laboratory’s disease-specific protocol: this is not a universal requirement for every stool assay or every patient. 16

Time-sensitive methods need advance coordination. A study involving 488 schoolchildren’s stool specimens on Pemba Island, Tanzania, documented declining hookworm egg counts on prepared Kato–Katz slides with delayed reading. It discusses a 30–60-minute reading window for hookworm. The practical action is to confirm that preparation and reading can occur within the validated interval; a slide left overnight is not equivalent to a correctly timed examination. 17

Urine timing can also help. CDC’s laboratory guidance notes greater S. haematobium egg excretion around midday and recommends collection at noon. Coordinate collection with the laboratory’s filtration or sediment-examination workflow and its transport instructions. 18

For specialised referrals, ask about preservation before collecting. CDC warns that formalin and several other fixatives are unsuitable for its stool molecular-detection workflows. Never add a preservative or apply a generic cold-storage rule without checking compatibility with the intended assay. 19

6. Interpret negative tests in the context of the question asked

Before reassuring a patient, check four things: the parasite the test could detect, the specimen submitted, the timing after exposure and whether handling requirements were met. This is a practical synthesis of the method, collection and lifecycle limitations above.

For schistosomiasis, egg shedding can be intermittent and scanty in light infections. CDC recommends three stool or urine specimens on different days to improve detection. For a recent exposure, antibody testing also has a window period: CDC advises waiting at least six to eight weeks after likely infection. In previously infected and treated patients, persistent antibodies may not distinguish active from resolved infection. 9

Urine dipstick blood needs careful interpretation. It can raise suspicion in an appropriate setting, but CDC does not consider it sufficiently sensitive or specific to establish an individual diagnosis. At the same time, MSF supports presumptive treatment in defined endemic clinical situations when parasitological confirmation cannot be obtained. These positions address different decisions: a supportive clinical finding may justify protocol-based action without becoming definitive proof. 9 20

For persistent suspicion after a negative result, contact the laboratory or referral service and choose the next step deliberately: repeat the appropriate specimen, use a more suitable method or investigate another diagnosis. Repeating the wrong test is unlikely to resolve the original uncertainty.

7. Treat possible strongyloidiasis as a specific safety issue

Before planned corticosteroid or other immunosuppressive treatment, review epidemiological risk and previous Strongyloides assessment. CDC particularly highlights patients starting these therapies, those with HTLV-1, haematological malignancy or transplantation, and people with persistent unexplained eosinophilia or relevant remote travel. 21

Routine stool microscopy is insufficient for exclusion. Specialised methods include Baermann concentration and agar plate culture. Serology can be helpful but has its own limitations, including cross-reactivity and persistence of antibodies after infection. An apparently reassuring single result should not override substantial concern in a high-risk patient. 7

If appropriate testing is unavailable and immunosuppression is imminent, obtain prompt senior or specialist advice about the local testing and presumptive-treatment pathway. CDC discusses considering empirical treatment in high-risk individuals when testing is unavailable, but this comes from traveller-focused guidance and is not a universal instruction to dispense ivermectin. Urgent essential treatment requires coordinated clinical decision-making. 22

Loa loa exposure is an important reason to avoid indiscriminate ivermectin. CDC warns that high Loa loa microfilarial loads can lead to encephalopathy after ivermectin and recommends screening before relevant antifilarial treatment in co-endemic areas. A local expert-supported pathway is particularly important for patients with relevant West or Central African exposure. 23

8. Recognise when symptoms need assessment beyond stool and urine microscopy

Genital schistosomiasis can be overlooked when attention is restricted to urinary eggs. Ask sensitively about pelvic pain, painful intercourse, abnormal discharge, contact bleeding or blood in semen where epidemiological exposure is relevant. WHO explains that laboratory confirmation can be insensitive and that genital lesions can resemble sexually transmitted infections and premalignant or malignant disease. 24

Arrange assessment by a clinician trained in genital examination and the differential diagnosis, with consent and privacy. Do not label persistent genital symptoms as an STI solely because routine parasite testing is negative, and do not assume schistosomiasis removes the need to investigate other causes. WHO’s pocket atlas supports recognition by healthcare professionals; it does not replace appropriate examination and referral. 24

Likewise, a normal stool result cannot exclude neurocysticercosis. CDC describes diagnosis through imaging and serology, and notes that negative antibody testing may occur with a single or small number of lesions. New neurological symptoms belong in an urgent medical pathway. 5

The broader lesson is anatomical: a stool test investigates what can be detected in stool. When the suspected disease involves other tissues or organs, select the appropriate referral pathway instead of repeatedly requesting the same specimen.

9. Separate preventive deworming from individual diagnosis

WHO recommends periodic deworming without prior individual diagnosis for specified at-risk groups in endemic settings. This is a public-health strategy to reduce morbidity; it is not evidence that every symptomatic patient has a worm infection or that the same medicine covers every helminth. 1

When testing is inaccessible, use the applicable national or locally approved clinical protocol. Document the suspected diagnosis, why treatment is being considered without confirmation, relevant precautions and the review plan. MSF provides examples of presumptive schistosomiasis management in endemic settings when reliable parasitological diagnosis cannot be obtained. Such guidance should be applied to the clinical context it describes, rather than expanded to all urinary or gastrointestinal complaints. 20

Pharmacists can help establish what was previously taken, check the prescribed regimen against the suspected infection and identify patients needing medical review. Nurses can support correct collection and ensure results reach the responsible clinician. Prescribers should reassess persistent symptoms rather than assume that another identical deworming course is the next diagnostic step.

10. Close the loop with a specific follow-up plan

Tell the patient when and how results will be available, who will interpret them and when review is needed if symptoms persist. Record the specimen dates and method alongside the result. WHO’s laboratory quality framework emphasises monitoring the complete testing process, including the stages before and after analysis. A result that never informs care leaves that process unfinished. 25

Follow-up should be infection-specific. CDC suggests repeat stool or urine examination one to two months after schistosomiasis treatment when eggs were demonstrated beforehand. For Strongyloides-positive stool examinations with persistent symptoms, CDC recommends follow-up stool testing two to four weeks after treatment. These are different clinical situations, not one universal “test of cure” timetable. 26 21

At review, reconsider adherence, continuing exposure, the original testing limitations and alternative diagnoses. Explain relevant prevention measures—sanitation, hygiene and safer exposure practices—without implying that advice alone eliminates the structural risks described by WHO. 1

A short consultation checklist

Before closing the encounter, confirm: Is urgent care needed? What exposure makes this infection plausible? Did we request the correct method and specimen? What would a negative result actually exclude? Who owns follow-up?

This checklist summarises the preceding guidance. It can support a team discussion or local job aid, but should be adapted to the tests, referral routes and clinical protocols available.

Three examples of applying the approach

The following are illustrative consultations, not reported cases or complete treatment algorithms.

A child with nocturnal itching and a negative stool result. The caregiver describes repeated perianal itching at night. Instead of treating the stool result as proof against pinworm, review the pattern and arrange the appropriate tape test. Explain collection before morning washing or toileting and how to return the specimen. Check for other causes if the history or examination is inconsistent. The key change is the sampling site: CDC notes that ordinary stool specimens usually contain too few pinworm eggs or worms for easy detection. 14

A patient with haematuria after freshwater exposure. Identify where and when exposure occurred and assess the patient clinically. Arrange the urine investigation appropriate to the suspected species, while considering other urinary causes. If a single specimen is negative but suspicion persists, use the laboratory’s repeat-sampling or referral pathway. Persistent or complicated symptoms need medical review, regardless of whether presumptive schistosomiasis treatment is offered under an endemic-area protocol. A supportive exposure history should guide care without becoming the explanation for every subsequent symptom. 20 28

An adult seeking another deworming course for fatigue. Assess pallor, functional limitation and clinical stability, and arrange haemoglobin assessment where available. Significant anaemia requires investigation and management beyond dispensing an anthelminthic. Review bleeding, nutritional and other clinical possibilities under the local protocol. If the person is unstable or shows decompensation, refer urgently. The diagnostic task is to determine what is causing the fatigue and whether urgent care is needed; possible hookworm infection is one part of that assessment. 4

For any referral, send the exposure location and dates, symptoms, relevant medicines, prior deworming and the actual laboratory reports. Identify the unresolved question—for example, possible Strongyloides before immunosuppression—so the receiving clinician can select an appropriate pathway. Agree how the patient will obtain the appointment and who will retrieve the result. This is a suggested implementation step based on the diagnostic principles above.

How DIDIDI aims to support frontline diagnosis

The practical gaps described here help explain DIDIDI’s focus on diagnostics usable closer to communities. The project is developing a smartphone-linked digital microscopy platform with on-device algorithms for helminth egg detection, alongside human-centred design and planned clinical and field evaluation in Uganda and Kenya. Its programme also addresses affordability, manufacturing and deployment. 27

For frontline professionals, the intended value is support for a more usable and consistent diagnostic workflow. Accuracy, operator requirements and clinical utility still need to be established through validation. An egg-detection platform should not be assumed to diagnose every helminth, overcome an unsuitable specimen or replace Strongyloides-specific assessment and specialist referral. 27

As these tools develop, the actions available today remain important: ask about exposure, collect the right specimen, understand the test’s limitations and make sure the patient receives the next appropriate step.

References

Sources checked on 2 November 2026. This educational guide focuses on diagnostic practice; treatment decisions and professional responsibilities should follow applicable national guidance. CDC traveller/refugee guidance is used for explicitly identified diagnostic and safety principles, not as a wholesale replacement for endemic-country protocols. Historical research estimates are labelled by study year.

  1. WHO (2023). Soil-transmitted helminth infections. www.who.int/news-room/fact-sheets/detail/soil-transmitted-helminth-infections

  2. Nikolay B, Brooker SJ, Pullan RL (2014). Sensitivity of diagnostic tests for human soil-transmitted helminth infections: a meta-analysis in the absence of a true gold standard. International Journal for Parasitology, 44, 765–774. pubmed.ncbi.nlm.nih.gov/24992655/

  3. Médecins Sans Frontières. Nematode infections. Clinical Guidelines. medicalguidelines.msf.org/en/viewport/CG/english/nematode-infections-16689807.html

  4. Médecins Sans Frontières. Anaemia. Clinical Guidelines. medicalguidelines.msf.org/en/viewport/CG/english/anaemia-16689138.html

  5. CDC (2024). Clinical Testing Guidance for Cysticercosis. www.cdc.gov/cysticercosis/hcp/diagnosis-testing/index.html

  6. CDC (2024). Clinical Treatment of Taeniasis. www.cdc.gov/taeniasis/hcp/clinical-care/index.html

  7. CDC (2026). Clinical Overview of Strongyloides. www.cdc.gov/strongyloides/hcp/clinical-overview/

  8. CDC (2025). Intestinal Parasites: Refugee Health Domestic Guidance. General diagnostic and biological principles; programme-specific recommendations require contextual interpretation. www.cdc.gov/immigrant-refugee-health/hcp/domestic-guidance/intestinal-parasites.html

  9. CDC (2024). Clinical Testing and Diagnosis for Schistosomiasis. www.cdc.gov/schistosomiasis/hcp/diagnosis-testing/

  10. CDC (2024). Clinical Overview of Taeniasis. www.cdc.gov/taeniasis/hcp/clinical-overview/

  11. WHO (2024). WHO guideline on preventive chemotherapy for public health control of strongyloidiasis. iris.who.int/bitstream/handle/10665/378257/9789240094024-eng.pdf

  12. CDC (2025). Post-Travel Parasitic Disease Including Evaluation of Eosinophilia. Yellow Book, 2026 edition. www.cdc.gov/yellow-book/hcp/post-travel-evaluation/post-travel-parasitic-disease.html

  13. WHO (2026). Schistosomiasis. Diagnostic methods. www.who.int/news-room/fact-sheets/detail/schistosomiasis

  14. CDC (2024). Clinical Overview of Pinworm Infection. www.cdc.gov/pinworm/hcp/clinical-overview/index.html

  15. CDC (2024). Diagnosing Pinworms. www.cdc.gov/pinworm/diagnosing/

  16. CDC DPDx. Stool Specimens—Specimen Collection. www.cdc.gov/dpdx/diagnosticprocedures/stool/specimencoll.html

  17. Bosch F et al. (2021). Diagnosis of soil-transmitted helminths using the Kato–Katz technique: What is the influence of stirring, storage time and storage temperature on stool sample egg counts? PLOS Neglected Tropical Diseases, 15, e0009032. journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0009032

  18. CDC DPDx (2016). Other Specimens—Urine Specimens. www.cdc.gov/dpdx/diagnosticprocedures/other/urine.html

  19. CDC DPDx (2020). Stool Specimens—Molecular Diagnosis. Receiving-laboratory requirements remain decisive. www.cdc.gov/dpdx/diagnosticprocedures/stool/moleculardx.html

  20. Médecins Sans Frontières. Schistosomiases. Clinical Guidelines. medicalguidelines.msf.org/en/viewport/CG/english/schistosomiases-16689787.html

  21. CDC (2024). Clinical Care of Strongyloides. www.cdc.gov/strongyloides/hcp/clinical-care/index.html

  22. CDC (2025). Perspectives: Screening Asymptomatic Travelers. Yellow Book, 2026 edition. www.cdc.gov/yellow-book/hcp/post-travel-evaluation/perspectives-screening-asymptomatic-travelers.html

  23. CDC (2024). Clinical Testing and Diagnosis for Loiasis. www.cdc.gov/filarial-worms/hcp/diagnosis-testing/index.html

  24. WHO (2020). Schistosomiasis: Genital manifestations. www.who.int/news-room/questions-and-answers/item/schistosomiasis-genital-manifestations

  25. WHO. Laboratory Quality Stepwise Implementation: Identify and start monitoring critical parameters—quality indicators. extranet.who.int/lqsi/content/identify-and-start-monitoring-critical-parameters-quality-indicators

  26. CDC (2024). Clinical Care of Schistosomiasis. www.cdc.gov/schistosomiasis/hcp/treatment/index.html

  27. DIDIDI. Project description. Published development and evaluation plans. www.dididi.eu/project/project-description

  28. CDC DPDx (2024). Schistosomiasis Infection. Species, specimen choice and diagnostic methods. www.cdc.gov/dpdx/schistosomiasis/